Structure Therapeutics (GPCR) Other Working Capital Changes (2022 - 2026)
Structure Therapeutics' (GPCR) quarterly Other Working Capital Changes came in at $206000.0 in Q1 2026, up 144.88% year-on-year from $84122.8 in Q1 2025, and up 134.16% quarter-over-quarter from -$603000.0 in Q4 2025.
Structure Therapeutics (GPCR) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Structure Therapeutics' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at $206000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 144.88% year-over-year to $206000.0 in Q1 2026; TTM through Mar 2026 was -$1.6 million, a 5.28% increase from a year earlier, with the FY2025 full-year figure at -$2.3 million, down 44.31% from the prior year.
- Other Working Capital Changes grew to $206000.0 in Q1 2026 per GPCR's latest filing, from -$603000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $9.1 million in Q4 2025 and bottomed at -$2.4 million in Q2 2024.
- The 5-year median for Other Working Capital Changes is $893000.0 (2022), against an average of $1.8 million.
- Across the five-year window, Other Working Capital Changes plunged 636.62% in 2024 and jumped 144.88% in 2026, its largest moves.
- Year by year, Other Working Capital Changes stood at -$84000.0 in 2022, then gained by 15.48% to -$71000.0 in 2023, then plunged by 636.62% to -$523000.0 in 2024, then slipped by 15.3% to -$603000.0 in 2025, then jumped by 134.16% to $206000.0 in 2026.
- Per Business Quant, the three latest GPCR Other Working Capital Changes figures stand at $206000.0 (Q1 2026), -$603000.0 (Q4 2025), and -$601000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Structure Therapeutics | 11.04 Bn | 11.04 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 206,000.00 |
| Mar 31, 2026 | 206,000.00 |
| Mar 31, 2026 | 206,000.00 |
| Dec 31, 2025 | -603,000.00 |
| Dec 31, 2025 | -603,000.00 |
| Dec 31, 2025 | -603,000.00 |
| Sep 30, 2025 | -601,000.00 |
| Sep 30, 2025 | -601,000.00 |
| Sep 30, 2025 | -601,000.00 |
| Jun 30, 2025 | -633,000.00 |
| Jun 30, 2025 | -633,000.00 |
| Jun 30, 2025 | -633,000.00 |
| Mar 31, 2025 | -459,000.00 |
| Mar 31, 2025 | -459,000.00 |
| Mar 31, 2025 | -459,000.00 |
| Dec 31, 2024 | -523,000.00 |
| Dec 31, 2024 | -523,000.00 |
| Dec 31, 2024 | -523,000.00 |
| Sep 30, 2024 | -289,000.00 |
| Sep 30, 2024 | -289,000.00 |